Mainstay Medical completed enrollment for its randomized clinical trial for its ReActiv8 restorative neurostimulation device, according to an Aug. 29 news release.
The study will evaluate ReActiv8 compared to a patient's optimal medical management, according to a news release. ReActiv8 is designed to help patients with intractable chronic low back pain.
The trial will be done at 25 centers in the U.S.